pentobarbital decreases amounts of panobinostat by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Potent CYP3A4 inducers can minimize panobinostat amounts by ~70% and cause cure failure. pentobarbital will lessen the level or impact of naloxegol by influencing hepatic/int